ES2055535T3 - Derivados de amina. - Google Patents

Derivados de amina.

Info

Publication number
ES2055535T3
ES2055535T3 ES91303275T ES91303275T ES2055535T3 ES 2055535 T3 ES2055535 T3 ES 2055535T3 ES 91303275 T ES91303275 T ES 91303275T ES 91303275 T ES91303275 T ES 91303275T ES 2055535 T3 ES2055535 T3 ES 2055535T3
Authority
ES
Spain
Prior art keywords
alkyl
alkenyl
hydrogen
phenyl
phenylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91303275T
Other languages
English (en)
Inventor
Stuart Dennett Mills
Rodney Brian Hargreaves
Bernard Joseph Mcloughlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of ES2055535T3 publication Critical patent/ES2055535T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS COMPUESTOS DE AMINOPIRIDINIO QUE TIENEN LA FORMULA GENERAL I EN DONDE R ELEVADO 1, R (AL CUADRADO) , R ELEVADO 3, R ELEVADO 5 Y R ELEVADO 6 SE SELECCIONAN DE UNA DE LAS SIGUIENTES COMBINACIONES: (A) UNO DE R (AL CUADRADO) Y R ELEVADO 6 ES UN GRUPO BASICO SELECCIONADO DEL AMINO, ALQUILAMIO O DIALQUILAMINO DE HASTA OCHO ATOMOS DE CARBONO, PIRROLIDINO, PIPERIDINO Y MORFOLINO, O ES ALQUILO, ALQUENILO, ALCOXIALQUILO, ALCOXI, ALQUILTIO, FENILO, FENILALQUILO, CICLOALQUILO O CICLOALQUILALQUILO; Y EL OTRO DE R (AL CUADRADO) Y R ELEVADO 6 ES HIDROGENO, ALQUILO O UNO DE LOS GRUPOS BASICOS ARRIBA DEFINIDOS, R ELEVADO 1 ES ALQUILO, ALQUENILO, CICLOALQUILO, FENILO, FENILALQUILO, CICLOALQUILALQUILO; Y R ELEVADO 3 Y R ELEVADO 5 SON INDEPENDIENTEMENTE HIDROGENO, ALQUILO O ALQUENILO; (B) R (AL CUADRADO) ES UN GRUPO BASICO COMO SE HA DEFINIDO ARRIBA, R ELEVADO 5 Y R ELEVADO 6 JUNTOS FORMAN ALQUILENO O, JUNTO CON LOS ATOMOS DE CARBONO AÑADIDOS DEL ANILLO DE PIRIDINA, COMPLETANUN ANILLO DE BENCENO; R ELEVADO 1 TIENE CUALQUIERA DE LOS SIGNIFICADOS DEFINIDOS ARRIBA EN (A); Y R ELEVADO 3 ES HIDROGENO, ALQUILO O ALQUENILO; Y (C) R (AL CUADRADO) TIENE CUALQUIERA DE LOS SIGNIFICADOS DEFINIDOS ARRIBA Y R ELEVADO 6 ES UN GRUPO QUE TIENE LA FORMULA -NR ELEVADO 7.AUNTO CON R ELEVADO 1 FORMA UN ENLACE ETILENO, TRIMETILENO O TETRAMETILENO Y R ELEVADO 7 ES HIDROGENO O ALQUILO; Y R ELEVADO 3 Y R ELEVADO 5 TIENEN, INDEPENDIENTEMENTE, CUALQUIERA DE LOS SIGNIFICADOS ARRIBA DEFINIDOS EN (A); Y DONDE R ELEVADO 4 ES HIDROGENO, CICLOALQUILALQUILO, ALQUILO, ALQUENILO, ALQUINILO O FENILALQUILO; Y Q ES FENILO, O EL GRUPO Q.N(R ELEVADO 4) CONSTITUYE UNA PORCION AZAHETEROCICLICA; Y ES UN ANION ACEPTABLE FISIOLOGICAMENTE; Y CUALQUIER UNO O MAS DE DICHAS PORCIONES DE FENILO O BENCENO PUEDEN SER NO SUSTITUIDOS OPCIONALMENTE O SOPORTAR UNO O MAS SUSTITUYENTES SELECCIONADO. LA INVENCION INCLUYE TAMBIEN CIERTOS DERIVADOS DE BASE DE ANHIDRO ESTRECHAMENTE RELACIONADOS QUE, AL IGUAL QUE LOS COMPONENTES DE LA FORMULA I, POSEEN EFECTOS BENEFICIOSOS EN EL SISTEMA CARDIOVASCULAR. TAMBIEN SE INCLUYEN COMPUESTOS FARMACEUTICOS Y PROCESOS PARA LA FABRICACION DE VARIOS COMPUESTOS NUEVOS.
ES91303275T 1990-04-19 1991-04-12 Derivados de amina. Expired - Lifetime ES2055535T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909008818A GB9008818D0 (en) 1990-04-19 1990-04-19 Amine derivatives

Publications (1)

Publication Number Publication Date
ES2055535T3 true ES2055535T3 (es) 1994-08-16

Family

ID=10674667

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91303275T Expired - Lifetime ES2055535T3 (es) 1990-04-19 1991-04-12 Derivados de amina.

Country Status (17)

Country Link
US (1) US5654298A (es)
EP (1) EP0453197B1 (es)
JP (1) JP3068875B2 (es)
AT (1) ATE107286T1 (es)
AU (1) AU642482B2 (es)
CA (1) CA2040107A1 (es)
DE (1) DE69102481T2 (es)
DK (1) DK0453197T3 (es)
ES (1) ES2055535T3 (es)
FI (1) FI911925A (es)
GB (1) GB9008818D0 (es)
IE (1) IE64361B1 (es)
IL (1) IL97751A0 (es)
NO (1) NO911347L (es)
NZ (1) NZ237689A (es)
PT (1) PT97396B (es)
ZA (1) ZA912672B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545535A (en) * 1993-04-13 1996-08-13 Molecular Probes, Inc. Fluorescent assay for bacterial gram reaction
US5436134A (en) * 1993-04-13 1995-07-25 Molecular Probes, Inc. Cyclic-substituted unsymmetrical cyanine dyes
US5445946A (en) * 1993-04-13 1995-08-29 Molecular Probes, Inc. Intravacuolar stains for yeast and other fungi
US5534416A (en) * 1993-04-13 1996-07-09 Molecular Probes, Inc. Fluorescent viability assay using cyclic-substituted unsymmetrical cyanine dyes
FR2737496B1 (fr) * 1995-07-31 1997-12-19 Centre Nat Rech Scient 4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih 1 et 2
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US7618975B2 (en) * 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7776529B2 (en) 2003-12-05 2010-08-17 Life Technologies Corporation Methine-substituted cyanine dye compounds
WO2006034474A2 (en) * 2004-09-23 2006-03-30 Reddy Us Therapeutics, Inc. Novel pyridine compounds, process for their preparation and compositions containing them
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
JP5306811B2 (ja) 2005-05-11 2013-10-02 ライフ テクノロジーズ コーポレーション ２本鎖ｄｎａへの高い選択性を有する蛍光化学物質及びそれらの使用
ES2587014T3 (es) * 2006-11-24 2016-10-20 Ac Immune S.A. Derivados de N-(metil)-piridin-2-amina para el tratamiento de enfermedades asociadas a proteínas amiloides o de tipo amiloide
WO2023151560A1 (en) * 2022-02-08 2023-08-17 Etern Biopharma (Shanghai) Co., Ltd. Bicyclic heteroaryl compounds and uses thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB815833A (en) * 1956-09-26 1959-07-01 Boots Pure Drug Co Ltd Phenanthridine compounds
BE492034A (es) * 1948-11-05
US2748124A (en) * 1954-05-06 1956-05-29 Searle & Co 1-(4-anilino-2-pyrimidino)-3-alkylureas
GB814947A (en) * 1954-08-16 1959-06-17 Geigy Ag J R Improvements in and relating to plant growth influencing compositions
US2845425A (en) * 1956-10-04 1958-07-29 Lilly Co Eli Substituted aminopyrimidines
DE1241832B (de) * 1963-02-23 1967-06-08 Hoechst Ag Verfahren zur Herstellung von Pyrimidiniumverbindungen
DE1445740A1 (de) * 1963-09-04 1968-11-28 Bayer Ag Verfahren zur Herstellung von Bispyrimidinium-Verbindungen
NL131196C (es) * 1966-07-16
GB1229413A (es) * 1967-06-14 1971-04-21
BE786565A (fr) * 1971-07-23 1973-01-22 Upjohn Co Nouveaux oxydes de pyridine substitues et leur preparation
ZA743270B (en) * 1973-06-15 1975-05-28 Upjohn Co Anti-hypertensive compounds
IN142539B (es) * 1974-05-10 1977-07-23 Ciba Geigy India Ltd
US4339453A (en) * 1979-07-23 1982-07-13 Merck & Co., Inc. Antimicrobial aminopyrimidinium salts
US4287338A (en) * 1980-03-10 1981-09-01 The Upjohn Company Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
FR2524467A1 (fr) * 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2544315B1 (fr) * 1983-04-12 1985-07-05 Adir Polymethylene imines disubstituees, leurs procedes de preparation, et les compositions pharmaceutiques les renfermant
US4503050A (en) * 1983-06-02 1985-03-05 Riker Laboratories, Inc. Substituted imidazo[1,2-c]pyrimidines
EP0139613A1 (de) * 1983-08-29 1985-05-02 Ciba-Geigy Ag N-(2-Nitrophenyl)-4-aminopyrimidin-Derivate, deren Herstellung und Verwendung
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
JPS61218589A (ja) * 1985-03-26 1986-09-29 Eisai Co Ltd ５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体
DE3514073A1 (de) * 1985-04-18 1986-10-23 Hoechst Ag, 6230 Frankfurt Mehrfach substituierte pyridin-1-oxide, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
WO1987001706A2 (en) * 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
DE3703633A1 (de) * 1986-02-14 1987-08-20 Sandoz Ag Purin-derivate, ihre herstellung und sie enthaltende arzneimittel
US4729995A (en) * 1986-04-21 1988-03-08 Toyo Boseki Kabushiki Kaisha Pyrimidine 2,4-dioxamate compounds and pharmaceutical compositions
US5019565A (en) * 1986-05-02 1991-05-28 Ici Americas Inc. Fungicidal pyridyl imidates
DE3639563A1 (de) * 1986-11-20 1988-06-01 Basf Ag N-arylsulfonyl-n'-pyrimidyl(triazinyl) -harnstoffe
DE3717480A1 (de) * 1987-05-23 1988-12-01 Shell Agrar Gmbh & Co Kg Neue herbizid und mikrobizid wirksame 2,6-diaminopyrimidine
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
GB8808071D0 (en) * 1988-04-07 1988-05-11 Shell Int Research Triazine herbicides
GB8819494D0 (en) * 1988-08-16 1988-09-21 Ucb Sa Use of 2-amino-4-morpholino-6-propyl-1 3 5-triazines for preparation of psychotropic medicaments
GB8819493D0 (en) * 1988-08-16 1988-09-21 Ucb Sa 2-amino-4-morpholino-6-propyl-1 3 5-triazines
US4992448A (en) * 1989-10-24 1991-02-12 Hoechst-Roussel Pharmaceuticals Inc. Benzocycloalkylaminopyridinamines and related compounds as topical antiinflammatory agents for the treatment of skin disorders

Also Published As

Publication number Publication date
EP0453197B1 (en) 1994-06-15
NO911347L (no) 1991-10-21
FI911925A0 (fi) 1991-04-19
JP3068875B2 (ja) 2000-07-24
DK0453197T3 (da) 1994-10-24
IE64361B1 (en) 1995-07-26
AU7394391A (en) 1991-10-24
AU642482B2 (en) 1993-10-21
PT97396B (pt) 1998-08-31
PT97396A (pt) 1992-01-31
DE69102481T2 (de) 1994-09-29
ATE107286T1 (de) 1994-07-15
CA2040107A1 (en) 1991-10-20
GB9008818D0 (en) 1990-06-13
NO911347D0 (no) 1991-04-05
IL97751A0 (en) 1992-06-21
DE69102481D1 (de) 1994-07-21
JPH04224562A (ja) 1992-08-13
IE911024A1 (en) 1991-10-23
US5654298A (en) 1997-08-05
NZ237689A (en) 1993-11-25
ZA912672B (en) 1991-12-24
EP0453197A1 (en) 1991-10-23
FI911925A (fi) 1991-10-20

Similar Documents

Publication Publication Date Title
DE69403119D1 (de) Triazolopyrimidinderivate mit fungizider Aktivität
MY105637A (en) Pyrimidine derivatives
ES2055535T3 (es) Derivados de amina.
ATE197706T1 (de) Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen
HU907224D0 (en) Process for producing heterocyclic compounds
UA50722C2 (uk) Нітробензаміди, спосіб їх одержання (варіанти), фармацевтична композиція
JO1631B1 (en) Derivatives of permidine
IL101032A0 (en) 1,2,4-triazolo(1,5-a)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 453197

Country of ref document: ES